First Trust Nasdaq-1 (QQEW) 43.09 $QQEW BUYINS.NET:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
First Trust Nasdaq-1 (QQEW) 43.09 $QQEW

BUYINS.NET: SWFT, JCTCF, GTE, BLDR, GRES, QQEW Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Jan 21, 6:30AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Swift Transportation Co (NYSE:SWFT), Jewett-Cameron Trading Company Ltd (NASDAQ:JCTCF), GRAN TIERRA ENERGY INC (NYSE:GTE), Builders Firstsource Inc (NASDAQ:BLDR), IQ ARB Global Resources ETF (NYSE:GRES), First Trust Portfolios LP (NASDAQ:QQEW) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
SWFT: 16.69 (+0.79), QQEW: 43.09 (+0.77), GRES: 25.73 (+0.23), BLDR: 12.34 (+0.52), GTE: 2.92 (+0.03), JCTCF: 11.10 (-0.20)

Nasdaq Outperforms: 3 ETFs in Focus
Zacks Equity Research - Zacks Investment Research - Wed Dec 30, 12:45PM CST
As the Nasdaq is likely to continue its positive trend in the near term, these three ETFs will remain in focus.
AMZN: 745.81 (+9.24), QQQ: 110.30 (+1.68), ONEQ: 195.00 (+3.24), IBB: 271.13 (+3.29), QQEW: 43.09 (+0.77), GOOGL: 717.78 (+10.52), MSFT: 52.30 (+0.92), AAPL: 96.68 (+0.74), XLE: 67.71 (+0.89)

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
BusinessWire - Tue Dec 22, 4:11PM CST
First Trust Advisors L.P. ("FTA" announces the declaration of distributions for 85 of 97 exchange-traded funds advised by FTA.
FPE: 19.22 (+0.05), FKU: 31.85 (+0.88), FTSL: 48.07 (+0.14), AIRR: 18.95 (+0.63), QABA: 37.93 (+0.66), FEP: 26.75 (+0.57), GRID: 35.66 (+1.37), FTSM: 59.92 (+0.01), QTEC: 43.96 (+0.89), FV: 22.65 (+0.37), FSZ: 37.78 (+0.30), FPA: 27.38 (-0.08), IFV: 16.45 (+0.27), FDIV: 50.26 (-0.29), FMK: 26.60 (+0.35), QQXT: 40.15 (+0.69), RDVY: 20.55 (+0.35), FEM: 19.43 (+0.56), CARZ: 30.21 (+0.72), BICK: 20.51 (+0.11), TDIV: 27.08 (+0.43), FCA: 18.56 (+0.24), FEMS: 30.20 (+0.82), FDTS: 32.22 (+0.13), HYLS: 48.16 (+0.21), TUSA: 24.78 (+0.06), FCVT: 25.08 (-0.72), MDIV: 19.39 (+0.15), FTRI: 10.53 (+0.23), QQEW: 43.09 (+0.77), FEMB: 43.38 (+0.69), YDIV: 16.65 (-0.05), FDT: 44.80 (+0.62), FMB: 54.07 (-0.02), FCAN: 23.18 (+0.17), FTHI: 20.02 (+0.07), FLM: 44.29 (unch), FTLB: 19.20 (-0.30), QINC: 22.63 (+0.30), FTCS: 40.51 (+0.57), FONE: 37.30 (+0.95), FHK: 32.43 (+0.47), SKYY: 30.75 (+0.64), FJP: 45.40 (+0.13), CIBR: 17.60 (+0.49), LMBS: 51.90 (+0.03), FTAG: 20.31 (+0.50)

Equal-Weight ETFs for a Potential Shift in Nasdaq Leaders
ETFtrends.com - ETF Trends - Tue Dec 22, 4:00PM CST
The so-called FANG stocks – Facebook (NasdaqGS: FB), Amazon (NasdaqGS: AMZN), Netflix (NasdaqGS: NFLX) and Google or Alphabet (NasdaqGS: GOOG) – have been among the best performers this year. However, the outperformance may not last, and...
QQQ: 110.30 (+1.68), QQEW: 43.09 (+0.77), QQQE: 64.14 (+1.12)

4 ETFs to Watch on PayPal Addition to Nasdaq-100
Zacks Equity Research - Zacks Investment Research - Fri Nov 06, 11:43AM CST
As PayPal is joining the Nasdaq-100 index, these ETFs are worth a look.
IPAY: 23.82 (+0.61), EBAY: 24.61 (+0.68), QQQ: 110.30 (+1.68), BRCM: 54.67 (+0.17), QQEW: 43.09 (+0.77), PYPL: 37.36 (+1.04), QQQE: 64.14 (+1.12)

The Top Tech ETFs in the Market
Jamal Carnette, The Motley Fool - Motley Fool - Sun Nov 01, 7:07AM CST
Source: Flickr user  GotCredit . Over the last decade, there's been no larger disruption in retail investing than the exchange-traded fund. According to Goldman partner Robert Boroujerdi, total ETF assets under management increased 24% per year...
QQQ: 110.30 (+1.68), TDIV: 27.08 (+0.43), QQEW: 43.09 (+0.77)

Cap-Weighted ETFs are Trumping Equal-Weight Rivals This Year
ETFtrends.com - ETF Trends - Wed Aug 05, 7:20AM CDT
Long heralded as advantageous due to their ability to mitigate single-stock risk, equal-weight exchange traded funds are trailing their cap-weighted rivals this year. In the essence of fairness, not all equal-weight ETFs are lagging their...
RYH: 154.86 (+1.84), RSP: 81.60 (+1.50), QQEW: 43.09 (+0.77), RHS: 130.16 (+1.37)

BUYINS.NET: QQEW, FBT, KXI, RXI, EQL, SNTA Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Aug 04, 7:20AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of First Trust Portfolios LP (NASDAQ:QQEW), First Trust NYSE Arca Biotechnology Index Fund (NYSE:FBT), iShares S&P Global Consumer Staples Index Fund (NYSE:KXI), iShares S&P Global Consumer Discrtnry Sectr Idx Fd (NYSE:RXI), Alps Equal Sector (NYSE:EQL), Synta Pharmaceuticals Corp (NASDAQ:SNTA) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
RXI: 85.99 (+1.68), KXI: 100.53 (+0.62), SNTA: 0.28 (unch), FBT: 93.72 (+0.78), EQL: 58.55 (+1.14), QQEW: 43.09 (+0.77)

Nasdaq & Emerging Market: Two ETFs Trading with Outsized Volume - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Jul 24, 5:00AM CDT
Heavier-than-normal volume put these Nasdaq and emerging market ETFs in focus.In the past trading session, U.S. stocks were in the bearish territory as an overall negative tone from recent earnings took a beating on the market. For the top ETFs, investors saw SPY shed 0.6%, DIA lose over 0.6% and QQQ move down by about 0.4% on the day. Two more specialized ETFs are worth noting though as both saw trading volume that was far outside of normal. In fact, both these funds experienced volume levels that were more than double their average for the most recent trading session. This could make these ETFs ones to watch out for in the days ahead to see if this trend of extra-interest continues: QQEW: Volume 3.55 times average This Nasdaq-100 equal weighted ETF was in focus yesterday as roughly 308,000 shares moved hands compared to an average of roughly 87,000 shares. We also saw some stock price movement as QQEW lost about 0.04%. The move was largely the result of the recent Apple-induced volatility in Nasdaq as these can have a big impact on tech stocks like what we find in this ETF’s portfolio. For the last one-month period, QQEW was down 0.7%. The fund carries a Zacks ETF Rank #3 (Hold). TLTE: Volume 3.34 times average This emerging market ETF was under the microscope yesterday as nearly 55,000 shares moved hands. This compares to an average trading day of about 16,000 shares. TLTE lost about 1% on the session. The big movement can largely be blamed on the sooner-than-expected prospect of a Fed rate hike as existing home sales jumped at the fastest pace in eight years in June while median home prices hit a record high on the back of economic well-being. Moreover, persistent economic turmoil in China S took the shine out of the emerging market. TLTE was down about 7% in the last one-month period and currently has a Zacks ETF Rank #3. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
SPY: 212.65 (+3.12), QQQ: 110.30 (+1.68), DIA: 181.30 (+2.51), QQEW: 43.09 (+0.77), TLTE: 44.42 (+0.82)

Apple Teaches Another Lesson in ETF Weighting
ETFtrends.com - ETF Trends - Thu Jul 23, 7:20AM CDT
Shares of Apple (NasdaqGS: AAPL) are fell 4.3% Wednesday and at one point during the session, the iPhone maker was lighter by $60 billion in market value after the company “disappointed” Wall Street by saying fiscal third-quarter profit rose...
QQQ: 110.30 (+1.68), XLK: 44.13 (+0.68), QQEW: 43.09 (+0.77), RYT: 95.53 (+2.05), QQQE: 64.14 (+1.12)

BUYINS.NET: THS, TAL, RFG, QQEW, SSO, MVV Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Jun 30, 7:45AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of TreeHouse Foods Inc (NYSE:THS), TAL International Group Inc (NYSE:TAL), Guggenheim Invest S&P MidCap 400 Pure Growth ETF (NYSE:RFG), First Trust Portfolios LP (NASDAQ:QQEW), Silver Standard Resources Inc (NYSE:SSO), ProShares Ultra MidCap400 (NYSE:MVV) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
RFG: 124.67 (+2.34), MVV: 79.14 (+2.86), SSO: 68.29 (+1.99), THS: 104.17 (+1.52), SSRI: 14.58 (+0.37), QQEW: 43.09 (+0.77), TAL: 14.79 (+1.28)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 207

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 378

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 171

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading

Top 5 Most Recently Viewed Articles

Trex Company Investigated for Securities Fraud: What Investors Need to Know

Updated Category News Views 181

Trex Company, Inc. Under Scrutiny for Securities Violations Trex Company, Inc. (NYSE: TREX) is currently facing an investigation regarding potential violations of federal securities laws. This inquiry is being conducted by the Law Offices of Howard G. Smith. The investigation stems from the company's recent financial disclosures, which raised concerns among investors....

Continue Reading
IRONMAN and Experience Oman Join Forces for Global Sports

Updated Category News Views 297

IRONMAN Partners with Experience Oman for a Dynamic Future The recent alliance between IRONMAN and Experience Oman marks a groundbreaking development in the realm of sports tourism. This partnership sets the stage for the prestigious IRONMAN 70.3 World Championship to take place in Oman, specifically in its capital of Muscat. Through this collaboration, Experience Oman...

Continue Reading
Exploring Quantica Tech's Innovative Quantic Bitcoin Initiative

Updated Category News Views 182

Introducing Quantic Bitcoin by Quantica Tech Quantica Tech, renowned for its innovations in quantum computing for blockchain, has embarked on an exciting project: Quantic Bitcoin (BTCQ). This initiative signifies a major leap towards integrating quantum computing capabilities into the decentralized finance landscape. With the development of a unique quantum...

Continue Reading
Exploring Integrity in NYC Real Estate Media Reporting

Updated Category News Views 227

Assessing the Reliability of Bisnow's NYC Real Estate Reporting In the fast-paced world of New York City's real estate market, the accuracy of information plays a crucial role for various stakeholders, including investors, lenders, and policy-makers. These groups rely heavily on precise reporting to navigate the complex and often unpredictable regulatory landscape....

Continue Reading
Citi Analysts Recommend Buying Microsoft After Share Pullback

Updated Category News Views 70

Citi Analysts Recommend Buying Microsoft After Share Pullback Recent insights from analysts at Citi suggest that investors should consider purchasing Microsoft (NASDAQ: MSFT) shares following a notable price drop. They believe this presents an opportunity, highlighting potential upside in the coming quarters for the tech giant. Understanding Microsoft’s Current...

Continue Reading